Skip to main content
Premium Trial:

Request an Annual Quote

Millennium, Compugen Ink Protein-Pathway R&D Collaboration

NEW YORK, March 20 - Compugen and Millennium Pharmaceuticals on Wednesday said they plan to co-develop software that can help researchers predict protein pathways that could be used in drug discovery and development.


Terms of the open-ended deal, announced on Wednesday, call for Compugen to apply its bioinformatics platform to Millennium's high-throughput technologies, especially its transcriptional profiling tools.


Though financial details of the collaboration were not disclosed, Compugen said that each partner will share the costs as well as the rights "to certain aspects" of the technology they develop.


The products that the partners hope to develop "are more general research tools" that can be used in a variety of disease applications, Mor Amitai, president and CEO of Compugen, said.


No other details were provided by a statement, and Amitai remained mum on specific aspects of the collaboration.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.